MedTrace Logo

Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding

NCT01155401 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2011-11-08

No results posted yet for this study

Summary

The purpose of this study is to determine and analyse the incidence, severity, risk factors and routine management of acute drug-induced upper gastrointestinal bleeding (UGIB) in the population of Russian patients

Conditions

  • Upper Gastrointestinal Bleeding

Sponsors & Collaborators

Principal Investigators

  • Boris R Gelfand, Prof · Department of the Russian State Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01155401 on ClinicalTrials.gov